Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor

Gary G. Schwartz, Esther M. John, Glovioell Rowland, Sue A. Ingles

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Background: prospective epidemiologic studies indicate that the risk for advanced prostate cancer is increased among men with high levels of serum calcium. Because serum calcium levels are influenced by the calcium-sensing receptor (CaSR), we examined prostate cancer in african american men in relation to three single nucleotide polymorphisms (sNps) in the CaSR gene, a986s, R990G and Q1011e. This is the first study of CaSR polymorphisms and risk of prostate cancer. Results: The CaSR genotypes were not associated with prostate cancer overall. however, we observed significant heterogeneity by disease stage for the Q1011E polymorphism (p = 0.02). advanced cases were significantly less likely than controls or localized cases to be homozygous for the minor allele of the Q1011E polymorphism (1% vs. 5%). Cases with advanced disease were six times less likely to carry two copies of the minor allele than were controls (OR = 0.16, p = 0.02) or localized cases (OR = 0.15, p = 0.01) and were significantly older at diagnosis (68.8 ± 5.7 vs. 64.0 ± 9.0 years for the QQ and ee genotypes, p = 0.004). Methods: We genotyped three CaSR sNps for 458 african american prostate cancer cases and 248 controls from a population-based case-control study, the California Collaborative prostate Cancer study. Conclusions: The CaSR Q1011E minor allele, which is common in populations with african ancestry, may be associated with a less aggressive form of prostate cancer among african american men.

Original languageEnglish (US)
Pages (from-to)994-999
Number of pages6
JournalCancer Biology and Therapy
Volume9
Issue number12
DOIs
StatePublished - Jun 15 2010

Fingerprint

Calcium-Sensing Receptors
African Americans
Prostatic Neoplasms
Alleles
Single Nucleotide Polymorphism
Genotype
Calcium
Serum
Population
Case-Control Studies
Epidemiologic Studies
Prospective Studies

Keywords

  • African-Americans
  • Calcium-sensing receptor
  • Genetics
  • Prostate cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Cite this

Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor. / Schwartz, Gary G.; John, Esther M.; Rowland, Glovioell; Ingles, Sue A.

In: Cancer Biology and Therapy, Vol. 9, No. 12, 15.06.2010, p. 994-999.

Research output: Contribution to journalArticle

Schwartz, Gary G. ; John, Esther M. ; Rowland, Glovioell ; Ingles, Sue A. / Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor. In: Cancer Biology and Therapy. 2010 ; Vol. 9, No. 12. pp. 994-999.
@article{db717e3d2f92485f9f78b60604f1790f,
title = "Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor",
abstract = "Background: prospective epidemiologic studies indicate that the risk for advanced prostate cancer is increased among men with high levels of serum calcium. Because serum calcium levels are influenced by the calcium-sensing receptor (CaSR), we examined prostate cancer in african american men in relation to three single nucleotide polymorphisms (sNps) in the CaSR gene, a986s, R990G and Q1011e. This is the first study of CaSR polymorphisms and risk of prostate cancer. Results: The CaSR genotypes were not associated with prostate cancer overall. however, we observed significant heterogeneity by disease stage for the Q1011E polymorphism (p = 0.02). advanced cases were significantly less likely than controls or localized cases to be homozygous for the minor allele of the Q1011E polymorphism (1{\%} vs. 5{\%}). Cases with advanced disease were six times less likely to carry two copies of the minor allele than were controls (OR = 0.16, p = 0.02) or localized cases (OR = 0.15, p = 0.01) and were significantly older at diagnosis (68.8 ± 5.7 vs. 64.0 ± 9.0 years for the QQ and ee genotypes, p = 0.004). Methods: We genotyped three CaSR sNps for 458 african american prostate cancer cases and 248 controls from a population-based case-control study, the California Collaborative prostate Cancer study. Conclusions: The CaSR Q1011E minor allele, which is common in populations with african ancestry, may be associated with a less aggressive form of prostate cancer among african american men.",
keywords = "African-Americans, Calcium-sensing receptor, Genetics, Prostate cancer",
author = "Schwartz, {Gary G.} and John, {Esther M.} and Glovioell Rowland and Ingles, {Sue A.}",
year = "2010",
month = "6",
day = "15",
doi = "10.4161/cbt.9.12.11689",
language = "English (US)",
volume = "9",
pages = "994--999",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "12",

}

TY - JOUR

T1 - Prostate cancer in African-American men and polymorphism in the calcium-sensing receptor

AU - Schwartz, Gary G.

AU - John, Esther M.

AU - Rowland, Glovioell

AU - Ingles, Sue A.

PY - 2010/6/15

Y1 - 2010/6/15

N2 - Background: prospective epidemiologic studies indicate that the risk for advanced prostate cancer is increased among men with high levels of serum calcium. Because serum calcium levels are influenced by the calcium-sensing receptor (CaSR), we examined prostate cancer in african american men in relation to three single nucleotide polymorphisms (sNps) in the CaSR gene, a986s, R990G and Q1011e. This is the first study of CaSR polymorphisms and risk of prostate cancer. Results: The CaSR genotypes were not associated with prostate cancer overall. however, we observed significant heterogeneity by disease stage for the Q1011E polymorphism (p = 0.02). advanced cases were significantly less likely than controls or localized cases to be homozygous for the minor allele of the Q1011E polymorphism (1% vs. 5%). Cases with advanced disease were six times less likely to carry two copies of the minor allele than were controls (OR = 0.16, p = 0.02) or localized cases (OR = 0.15, p = 0.01) and were significantly older at diagnosis (68.8 ± 5.7 vs. 64.0 ± 9.0 years for the QQ and ee genotypes, p = 0.004). Methods: We genotyped three CaSR sNps for 458 african american prostate cancer cases and 248 controls from a population-based case-control study, the California Collaborative prostate Cancer study. Conclusions: The CaSR Q1011E minor allele, which is common in populations with african ancestry, may be associated with a less aggressive form of prostate cancer among african american men.

AB - Background: prospective epidemiologic studies indicate that the risk for advanced prostate cancer is increased among men with high levels of serum calcium. Because serum calcium levels are influenced by the calcium-sensing receptor (CaSR), we examined prostate cancer in african american men in relation to three single nucleotide polymorphisms (sNps) in the CaSR gene, a986s, R990G and Q1011e. This is the first study of CaSR polymorphisms and risk of prostate cancer. Results: The CaSR genotypes were not associated with prostate cancer overall. however, we observed significant heterogeneity by disease stage for the Q1011E polymorphism (p = 0.02). advanced cases were significantly less likely than controls or localized cases to be homozygous for the minor allele of the Q1011E polymorphism (1% vs. 5%). Cases with advanced disease were six times less likely to carry two copies of the minor allele than were controls (OR = 0.16, p = 0.02) or localized cases (OR = 0.15, p = 0.01) and were significantly older at diagnosis (68.8 ± 5.7 vs. 64.0 ± 9.0 years for the QQ and ee genotypes, p = 0.004). Methods: We genotyped three CaSR sNps for 458 african american prostate cancer cases and 248 controls from a population-based case-control study, the California Collaborative prostate Cancer study. Conclusions: The CaSR Q1011E minor allele, which is common in populations with african ancestry, may be associated with a less aggressive form of prostate cancer among african american men.

KW - African-Americans

KW - Calcium-sensing receptor

KW - Genetics

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77954409303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954409303&partnerID=8YFLogxK

U2 - 10.4161/cbt.9.12.11689

DO - 10.4161/cbt.9.12.11689

M3 - Article

C2 - 20364112

AN - SCOPUS:77954409303

VL - 9

SP - 994

EP - 999

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 12

ER -